Dishman Carbogen Amcis Limited (BOM:540701)

Market Cap	34.22B
Revenue (ttm)	26.50B
Net Income (ttm)	-1.10B
Shares Out	n/a
EPS (ttm)	-7.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,480
Average Volume	20,054
Open	216.95
Previous Close	215.45
Day's Range	213.50 - 218.20
52-Week Range	132.75 - 307.80
Beta	n/a
RSI	59.05
Earnings Date	May 26, 2025

About Dishman Carbogen Amcis

Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical, healthcare, and bio-technology industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients (APIs), and general and highly potent APIs; specialty chemicals comprising intermediates, fine chemicals, phosphoranes, solid quaternary ammonium compounds, wittig reagents, and various pharmaceutica...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1983
• Employees: 1,132
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540701

Financial Performance

In 2023, Dishman Carbogen Amcis's revenue was 26.16 billion, an increase of 8.41% compared to the previous year's 24.13 billion. Losses were -1.53 billion, 414.9% more than in 2022.